Pro-Dex (PDEX)
Builds powered surgical handpieces and repair programs for medical-device OEM customers.
Something off on this page? Send us feedback.
Designs and manufactures powered surgical drivers, shavers, and air motors for medical-device OEMs, then supports them with repairs and prototype work. The business runs as one segment and is shaped by exclusive supply agreements with a highly concentrated customer base.
Designs and manufactures autoclavable battery-powered and electric surgical drivers, shavers, and related handpieces used in orthopedic, thoracic, and craniomaxillofacial procedures. Finished devices sit alongside repair programs, prototype work, and a smaller line of precision air motors.
Works mainly as an OEM and turnkey development partner rather than a broad consumer-facing brand, with machining in Irvine and assembly in Tustin. Patented torque-limiting and sealing technology, plus regulated manufacturing support such as ISO 13485 and FDA registration, help anchor that role.
Sales are concentrated in medical devices and repairs, while legacy industrial air motors and remaining dental components play a minor role. Demand is heavily tied to a small set of customers under exclusive supply agreements, including one customer that accounts for most revenue.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $9.3M · Total debt $18.1M · Total assets $74.5M · Shareholders' equity $47.6M
- Revenue
- $20.4M
- Operating income
- $3.5M
- Net income
- $2.9M
No dividends on record.
| Institutions | 23.15% | 741.6K shares | |
|---|---|---|---|
| 69 holders · as of Jun 30, 2026 | |||
| Insiders | 44.85% | 1.44M shares | |
| 8 holders · as of Sep 14, 2026 | |||
| Other | 32.00% | 1.03M shares | |
| remainder | |||
3.20M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Nicholas John SwensonInsiderdirector, 10 percent owner | 31.77% | 1.02M | filed Jun 26, 2026 |
Raymond E. CabillotInsiderdirector, 10 percent owner | 8.52% | 272,846 | filed Nov 21, 2025 |
BlackRock, Inc.Institution | 4.78% | 153,178 | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 2.57% | 82,283 | as of Jun 30, 2026 |
Richard Lee Jr van KirkInsiderdirector, officer: Chief Executive Officer | 2.47% | 79,228 | filed Sep 14, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Sep 11, 2026 | Richard Lee Jr van Kirk | director, officer: Chief Executive Officer | −765 | $59.36 |
| Sep 9, 2026 | Richard Lee Jr van Kirk | director, officer: Chief Executive Officer | −19,235 | $60.58 |
| Sep 9, 2026 | Alisha Charlton | officer: Chief Financial Officer | −2,300 | $61.30 |
| Mar 16, 2026 | Angelita Rebamontan Domingo | director | −998 | $47.24 |
| May 22, 2026 | Richard Lee Jr van Kirk | director, officer: Chief Executive Officer | −4,128 | $62.36 |
- CONMED
Powered orthopedic tools and shavers in the same procedure mix
- Stryker
Broad orthopedic power platforms and repair services in shared ORs
- Zimmer Biomet
Orthopedic and CMF power systems with broader procedural breadth
- Johnson & Johnson
Small-bone and trauma power tools across orthopedic and thoracic cases
- Smith & Nephew (ADR)
Arthroscopic shavers and sports-medicine towers in shared resection work
CompareAfter hours
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Pro-Dex | $72.41 | +0.08% | $231.5M | 17.6 | 23.5 | 3.0 | +16.6% |
| CONMED | $46.17 | +0.07% | $1.34B | 24.1 | 10.3 | 1.0 | +0.3% |
| Stryker | $275.09 | +0.01% | $105.11B | 28.4 | 17.2 | 4.1 | +9.4% |
| Zimmer Biomet | $93.98 | −0.04% | $18.25B | 22.9 | 10.7 | 2.1 | +4.8% |
| Johnson & Johnson | $269.09 | −0.07% | $649.40B | 31.2 | 22.7 | 6.6 | +6.6% |
| Smith & Nephew (ADR) | $27.49 | −0.02% | $11.63B | 19.0 | — | 1.8 | +4.6% |
| Median | 24.1 | 14.0 | 2.1 | +4.8% |